Clinical Cases in Colorectal Cancer: Adherence to the ESMO Clinical Practice Guidelines

 

 

As part of ESMO's continuous commitment to offering beneficial educational material relevant to your work and practice in order to receive your certificate, please complete the Evaluation Survey, which will take approximately 5 minutes. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did your undertaking of this E-Learning module allow you to understand factors such as tumor characteristics, patient’s condition and comorbidities, and patient preferences and their importance for decision making in the adjuvant treatment of patients with colon cancer? (1-not at all; 5-a lot)

2. Did your undertaking of this E-Learning module allow you to discuss strengths, limitations, and clinical implications of data from trials of adjuvant treatment for colon cancer in the context of evidence-based medicine and emerged clinical practice guideline? (1-not at all; 5-a lot)

3. Did your undertaking of this E-Learning module allow you to discuss the use of adjuvant chemotherapy in colon cancer, as well as the data supporting movement towards a more personalised patient-specific and tumor-specific approach to treating primary colon cancer? (1-not at all; 5-a lot)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-completely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestions to improve future ESMO E-Learning material, please write in the box below: